Search

Misook Yu

Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642, 1641
Total Applications
878
Issued Applications
268
Pending Applications
204
Abandoned Applications
408

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4663126 [patent_doc_number] => 20080254033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases' [patent_app_type] => utility [patent_app_number] => 10/586669 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20161 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254033.pdf [firstpage_image] =>[orig_patent_app_number] => 10586669 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586669
Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases Jan 20, 2005 Abandoned
Array ( [id] => 4663126 [patent_doc_number] => 20080254033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases' [patent_app_type] => utility [patent_app_number] => 10/586669 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20161 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254033.pdf [firstpage_image] =>[orig_patent_app_number] => 10586669 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586669
Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases Jan 20, 2005 Abandoned
Array ( [id] => 7110563 [patent_doc_number] => 20050208018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth' [patent_app_type] => utility [patent_app_number] => 11/040162 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 19873 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208018.pdf [firstpage_image] =>[orig_patent_app_number] => 11040162 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/040162
Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth Jan 19, 2005 Issued
Array ( [id] => 5296025 [patent_doc_number] => 20090010951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Epitope/Peptide Recognized By Hla-A2402-Restricted Ep/Cam-Specific Ctl And Use Of The Same' [patent_app_type] => utility [patent_app_number] => 10/586852 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13837 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20090010951.pdf [firstpage_image] =>[orig_patent_app_number] => 10586852 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/586852
Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same Jan 18, 2005 Issued
Array ( [id] => 7196119 [patent_doc_number] => 20050164267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Compositions and methods for identifying and targeting cancer cells of alimentary canal origin' [patent_app_type] => utility [patent_app_number] => 11/036875 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14322 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164267.pdf [firstpage_image] =>[orig_patent_app_number] => 11036875 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/036875
Compositions and methods for identifying and targeting cancer cells of alimentary canal origin Jan 13, 2005 Issued
Array ( [id] => 4473982 [patent_doc_number] => 07867705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-11 [patent_title] => 'Frizzled proteins and detection and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/575627 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 48 [patent_no_of_words] => 36181 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/867/07867705.pdf [firstpage_image] =>[orig_patent_app_number] => 11575627 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/575627
Frizzled proteins and detection and treatment of cancer Jan 4, 2005 Issued
Array ( [id] => 7103894 [patent_doc_number] => 20050106620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Novel method of diagnosing, monitoring, staging, imaging and treating cancer' [patent_app_type] => utility [patent_app_number] => 11/022712 [patent_app_country] => US [patent_app_date] => 2004-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6832 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106620.pdf [firstpage_image] =>[orig_patent_app_number] => 11022712 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022712
Novel method of diagnosing, monitoring, staging, imaging and treating cancer Dec 26, 2004 Abandoned
Array ( [id] => 7045532 [patent_doc_number] => 20050250127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Methods for identifying modulators of MDA-7 mediated apoptosis' [patent_app_type] => utility [patent_app_number] => 11/019897 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14987 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250127.pdf [firstpage_image] =>[orig_patent_app_number] => 11019897 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/019897
Methods for identifying modulators of MDA-7 mediated apoptosis Dec 21, 2004 Abandoned
Array ( [id] => 7219161 [patent_doc_number] => 20050260555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Chemosensitivity measurement using caspase activity' [patent_app_type] => utility [patent_app_number] => 10/999158 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4446 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260555.pdf [firstpage_image] =>[orig_patent_app_number] => 10999158 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/999158
Chemosensitivity measurement using caspase activity Nov 29, 2004 Abandoned
Array ( [id] => 6983262 [patent_doc_number] => 20050153332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Method of diagnosing, monitoring, staging, imaging and treating colon cancer' [patent_app_type] => utility [patent_app_number] => 11/000263 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25978 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153332.pdf [firstpage_image] =>[orig_patent_app_number] => 11000263 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/000263
Method of diagnosing, monitoring, staging, imaging and treating colon cancer Nov 29, 2004 Abandoned
Array ( [id] => 7005703 [patent_doc_number] => 20050171016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Thrombospondin-2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/997699 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 25903 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171016.pdf [firstpage_image] =>[orig_patent_app_number] => 10997699 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997699
Thrombospondin-2 and uses thereof Nov 23, 2004 Abandoned
Array ( [id] => 7074768 [patent_doc_number] => 20050148036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response' [patent_app_type] => utility [patent_app_number] => 10/997648 [patent_app_country] => US [patent_app_date] => 2004-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19246 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148036.pdf [firstpage_image] =>[orig_patent_app_number] => 10997648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997648
Method for detecting a mononuclear cell phenotype related to a pro-tumor immune response Nov 23, 2004 Abandoned
Array ( [id] => 142063 [patent_doc_number] => 07691817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-06 [patent_title] => 'System and method for inhibiting cellular proliferation with tachykinins' [patent_app_type] => utility [patent_app_number] => 10/994170 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 17834 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/691/07691817.pdf [firstpage_image] =>[orig_patent_app_number] => 10994170 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994170
System and method for inhibiting cellular proliferation with tachykinins Nov 18, 2004 Issued
Array ( [id] => 4733417 [patent_doc_number] => 20080050396 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients' [patent_app_type] => utility [patent_app_number] => 10/580016 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20809 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0050/20080050396.pdf [firstpage_image] =>[orig_patent_app_number] => 10580016 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580016
Proteins belonging to the Bcl-2 family and fragments thereof, and their use in cancer patients Nov 17, 2004 Issued
Array ( [id] => 7252582 [patent_doc_number] => 20050142594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer' [patent_app_type] => utility [patent_app_number] => 10/983578 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7642 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142594.pdf [firstpage_image] =>[orig_patent_app_number] => 10983578 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/983578
DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer Nov 8, 2004 Abandoned
Array ( [id] => 7178069 [patent_doc_number] => 20050123969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer' [patent_app_type] => utility [patent_app_number] => 10/983577 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 7643 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123969.pdf [firstpage_image] =>[orig_patent_app_number] => 10983577 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/983577
DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer Nov 8, 2004 Abandoned
Array ( [id] => 5289927 [patent_doc_number] => 20090022657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Novel CXCL8 antagonists' [patent_app_type] => utility [patent_app_number] => 10/573726 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8897 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022657.pdf [firstpage_image] =>[orig_patent_app_number] => 10573726 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573726
Novel CXCL8 antagonists Oct 21, 2004 Abandoned
Array ( [id] => 177691 [patent_doc_number] => 07655399 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Methods for prenatal diagnosis of chromosomal abnormalities' [patent_app_type] => utility [patent_app_number] => 10/575119 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8944 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655399.pdf [firstpage_image] =>[orig_patent_app_number] => 10575119 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575119
Methods for prenatal diagnosis of chromosomal abnormalities Oct 7, 2004 Issued
Array ( [id] => 588381 [patent_doc_number] => 07435554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)' [patent_app_type] => utility [patent_app_number] => 10/954037 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 17760 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435554.pdf [firstpage_image] =>[orig_patent_app_number] => 10954037 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/954037
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) Sep 28, 2004 Issued
Array ( [id] => 564004 [patent_doc_number] => 07465554 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/952328 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7151 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465554.pdf [firstpage_image] =>[orig_patent_app_number] => 10952328 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952328
Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof Sep 28, 2004 Issued
Menu